Reported Earnings • Jul 31
Second quarter 2026 earnings released: EPS: €0.42 (vs €0.47 in 2Q 2025) Second quarter 2026 results: EPS: €0.42 (down from €0.47 in 2Q 2025). Revenue: €724.2m (up 4.3% from 2Q 2025). Net income: €80.4m (down 8.2% from 2Q 2025). Profit margin: 11% (down from 13% in 2Q 2025). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 4.7% p.a. on average during the next 3 years, compared to a 6.3% growth forecast for the Machinery industry in Italy. Declared Dividend • Jul 15
Dividend of €0.27 announced Shareholders will receive a dividend of €0.27. Ex-date: 8th December 2026 Payment date: 10th December 2026 Dividend yield will be 2.7%, which is higher than the industry average of 1.1%. Sustainability & Growth Dividend is covered by both earnings (70% earnings payout ratio) and cash flows (39% cash payout ratio). The dividend has increased by an average of 22% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 59% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Upcoming Dividend • Jul 03
Upcoming dividend of €0.26 per share Eligible shareholders must have bought the stock before 10 July 2026. Payment date: 14 July 2026. Payout ratio is a comfortable 70% and this is well supported by cash flows. Trailing yield: 3.2%. Lower than top quartile of Italian dividend payers (4.6%). Higher than average of industry peers (1.0%). Announcement • May 29
Fluidra Announces Chief Financial Officer Changes Fluidra announced that its Board of Directors has appointed Juan Graham as Chief Financial Officer. Graham will join the company and Fluidra’s Executive Committee on 1 June 2026, working closely with Xavier Tintoré over the coming months to ensure a smooth and well-coordinated transition. Xavier will step down as Chief Financial Officer on 1 August 2026 and will continue supporting the company until the end of the year as part of the transition. The appointment follows a planned and orderly succession process linked to Xavier Tintoré’s decision to begin a new professional and personal chapter after 16 years as Fluidra’s CFO. Juan Graham brings more than 25 years of international experience in senior finance roles, combining strong functional expertise with hands-on operational leadership. He spent nearly two decades at Johnson & Johnson, where he held senior leadership positions across consumer health, supply chain operations, treasury, mergers and acquisitions, and global finance. His experience includes leading finance organizations of significant scale and complexity, including supporting a business with more than $14 billion in annual revenue. Most recently, Graham served as CFO of U.S.-listed companies including FibroGen and Perspective Therapeutics, where he led finance, investor relations, IT and strategic planning functions through periods of transformation and growth. Tintoré has been a key figure in Fluidra’s transformation over the past 16 years, playing a central role not only in the company’s financial leadership, but also across strategy, investor relations, integration and transformation initiatives and several corporate functions. He was instrumental through some of the company’s most important milestones, including the merger with Zodiac, Fluidra’s inclusion in the IBEX 35, the company’s international expansion and numerous strategic acquisitions. Announcement • May 28
Fluidra Appoints Juan Graham to the Executive Committee, Effective 1 June 2026 Fluidra announced that Juan Graham will join the company and Fluidra’s Executive Committee on 1 June 2026, working closely with Xavier Tintoré over the coming months to ensure a smooth and well-coordinated transition. Juan Graham brings more than 25 years of international experience in senior finance roles, combining strong functional expertise with hands-on operational leadership. He spent nearly two decades at Johnson & Johnson, where he held senior leadership positions across consumer health, supply chain operations, treasury, mergers and acquisitions, and global finance. His experience includes leading finance organizations of significant scale and complexity, including supporting a business with more than $14 billion in annual revenue. Most recently, Graham served as CFO of U.S.-listed companies including FibroGen and Perspective Therapeutics, where he led finance, investor relations, IT and strategic planning functions through periods of transformation and growth. Declared Dividend • May 20
Dividend of €0.26 announced Shareholders will receive a dividend of €0.26. Ex-date: 10th July 2026 Payment date: 14th July 2026 Dividend yield will be 2.7%, which is higher than the industry average of 1.1%. Sustainability & Growth Dividend is covered by both earnings (70% earnings payout ratio) and cash flows (39% cash payout ratio). The dividend has increased by an average of 22% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 60% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Buy Or Sell Opportunity • May 08
Now 23% undervalued after recent price drop Over the last 90 days, the stock has fallen 20% to €19.53. The fair value is estimated to be €25.51, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 11%. For the next 3 years, revenue is forecast to grow by 4.5% per annum. Earnings are also forecast to grow by 16% per annum over the same time period. Declared Dividend • Apr 28
Final dividend of €0.26 announced Shareholders will receive a dividend of €0.26. Ex-date: 10th July 2026 Payment date: 14th July 2026 Dividend yield will be 2.3%, which is higher than the industry average of 1.1%. Sustainability & Growth Dividend is covered by both earnings (70% earnings payout ratio) and cash flows (45% cash payout ratio). The dividend has increased by an average of 22% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 56% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Reported Earnings • Mar 29
Full year 2025 earnings released: EPS: €0.93 (vs €0.73 in FY 2024) Full year 2025 results: EPS: €0.93 (up from €0.73 in FY 2024). Revenue: €2.25b (up 4.1% from FY 2024). Net income: €176.0m (up 28% from FY 2024). Profit margin: 7.8% (up from 6.4% in FY 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.5% p.a. on average during the next 3 years, compared to a 6.7% growth forecast for the Machinery industry in Italy. Buy Or Sell Opportunity • Mar 27
Now 26% undervalued after recent price drop Over the last 90 days, the stock has fallen 9.6% to €20.02. The fair value is estimated to be €26.96, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 11%. For the next 3 years, revenue is forecast to grow by 4.5% per annum. Earnings are also forecast to grow by 16% per annum over the same time period. Announcement • Mar 27
Fluidra, S.A., Annual General Meeting, May 06, 2026 Fluidra, S.A., Annual General Meeting, May 06, 2026. Location: ac hotel sant cugat, placa de xavier cugat, sant cugat del valles, barcelona., Spain Declared Dividend • Mar 08
Final dividend of €0.26 announced Shareholders will receive a dividend of €0.26. Ex-date: 10th July 2026 Payment date: 14th July 2026 Dividend yield will be 2.4%, which is higher than the industry average of 1.1%. Sustainability & Growth Dividend is covered by both earnings (70% earnings payout ratio) and cash flows (45% cash payout ratio). The dividend has increased by an average of 27% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 56% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Valuation Update With 7 Day Price Move • Mar 05
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to €20.90, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 17x in the Machinery industry in Italy. Simply Wall St's valuation model estimates the intrinsic value at €28.67 per share. Reported Earnings • Feb 27
Full year 2025 earnings released: EPS: €0.93 (vs €0.73 in FY 2024) Full year 2025 results: EPS: €0.93 (up from €0.73 in FY 2024). Revenue: €2.25b (up 4.1% from FY 2024). Net income: €176.0m (up 28% from FY 2024). Profit margin: 7.8% (up from 6.4% in FY 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.7% p.a. on average during the next 3 years, compared to a 6.8% growth forecast for the Machinery industry in Italy. Buy Or Sell Opportunity • Feb 27
Now 23% undervalued The stock has been flat over the last 90 days, currently trading at €22.64. The fair value is estimated to be €29.57, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 13%. For the next 3 years, revenue is forecast to grow by 4.7% per annum. Earnings are also forecast to grow by 16% per annum over the same time period. Valuation Update With 7 Day Price Move • Jan 08
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to €27.00, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 17x in the Machinery industry in Italy. Simply Wall St's valuation model estimates the intrinsic value at €26.24 per share. Buy Or Sell Opportunity • Nov 28
Now 20% overvalued Over the last 90 days, the stock has fallen 6.9% to €22.74. The fair value is estimated to be €18.88, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 3.3% over the last 3 years. Earnings per share has grown by 11%. For the next 3 years, revenue is forecast to grow by 4.2% per annum. Earnings are also forecast to grow by 15% per annum over the same time period. Upcoming Dividend • Nov 24
Upcoming dividend of €0.24 per share Eligible shareholders must have bought the stock before 01 December 2025. Payment date: 03 December 2025. Payout ratio is a comfortable 70% and this is well supported by cash flows. Trailing yield: 2.6%. Lower than top quartile of Italian dividend payers (4.8%). Higher than average of industry peers (1.3%). Announcement • Oct 30
Fluidra Reaffirms Its Guidance for Full Year 2025 Fluidra reaffirmed its guidance for full year 2025. The company remains on track to deliver its full-year 2025 guidance with expected sales between €2,160 and 2,220 million. Announcement • Jul 31
Fluidra, S.A. Updates Earnings Guidance for the Year 2025 Fluidra, S.A. updated earnings guidance for the year 2025. For the period, the company now expects sales to be between €2,160 and €2,220 million. Announcement • May 07
Fluidra, S.A. Reaffirms Earnings Guidance for the Year 2025 Fluidra, S.A. reaffirmed earnings guidance for the year 2025. The company is maintaining 2025 guidance as move into the key months of the pool season.